Receptor for Advanced Glycation End Products Is Involved in LPA(5)-Mediated Brain Damage after a Transient Ischemic Stroke
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sapkota, A. | - |
dc.contributor.author | Park, Sung Jean | - |
dc.contributor.author | Choi, Ji Woong | - |
dc.date.available | 2021-03-11T01:40:24Z | - |
dc.date.created | 2021-02-01 | - |
dc.date.issued | 2021-02 | - |
dc.identifier.issn | 0024-3019 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80378 | - |
dc.description.abstract | Lysophosphatidic acid receptor 5 (LPA5 ) has been recently identified as a novel pathogenic factor for brain ischemic stroke. However, its underlying mechanisms remain unclear. Here, we determined whether the receptor for advanced glycation end products (RAGE) could be involved in LPA5-mediated brain injuries after ischemic challenge using a mouse model of transient middle cerebral artery occlusion (tMCAO). RAGE was upregulated in the penumbra and ischemic core regions after tMCAO challenge. RAGE upregulation was greater at 3 days than that at 1 day after tMCAO challenge. It was mostly observed in Iba1-immunopositive cells of a post-ischemic brain. Suppressing LPA5 activity with its antagonist, TCLPA5, attenuated RAGE upregulation in the penumbra and ischemic core regions, particularly on Iba1-immunopositive cells, of injured brains after tMCAO challenge. It also attenuated blood–brain barrier disruption, one of the core pathogenesis upon RAGE activation, after tMCAO challenge. As an underlying signaling pathways, LPA5 could contribute to the activation of ERK1/2 and NF-κB in injured brains after tMCAO challenge. Collectively, the current study suggests that RAGE is a possible mediator for LPA5-dependent ischemic brain injury. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | LIFE-BASEL | - |
dc.title | Receptor for Advanced Glycation End Products Is Involved in LPA(5)-Mediated Brain Damage after a Transient Ischemic Stroke | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000622696800001 | - |
dc.identifier.doi | 10.3390/life11020080 | - |
dc.identifier.bibliographicCitation | LIFE-BASEL, v.11, no.2, pp.1 - 12 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85099737144 | - |
dc.citation.endPage | 12 | - |
dc.citation.startPage | 1 | - |
dc.citation.title | LIFE-BASEL | - |
dc.citation.volume | 11 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Sapkota, A. | - |
dc.contributor.affiliatedAuthor | Park, Sung Jean | - |
dc.contributor.affiliatedAuthor | Choi, Ji Woong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Blood–brain barrier | - |
dc.subject.keywordAuthor | Brain ischemic stroke | - |
dc.subject.keywordAuthor | ERK1/2 | - |
dc.subject.keywordAuthor | LPA5 | - |
dc.subject.keywordAuthor | NF-κB | - |
dc.subject.keywordAuthor | RAGE | - |
dc.subject.keywordAuthor | TCLPA5 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.